Article

VEGF Trap has potential for treating a wide range of ocular neovascular diseases

Animal studies show efficacy of VEGF Trap where VEGF is over-expressed in photoreceptors

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
1 expert in this video
Related Content
Q&A: Marion Munk on IntRIS symposium at EURETINA 2025
September 14th 2025

Q&A: Marion Munk on IntRIS symposium at EURETINA 2025

3 Things You Should Know About the GA Pipeline
September 14th 2025

NK Insights: An Interactive Corneal Sensitivity Testing Workshop

Q&A: Giuseppe Querques on PVAC and TelCaps
September 14th 2025

Q&A: Giuseppe Querques on PVAC and TelCaps

3 Things You Should Know About the GA Pipeline
September 14th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

New company OpZira formed following Alcon’s acquisition of LumiThera
September 14th 2025

New company OpZira formed following Alcon’s acquisition of LumiThera

SAR402663 earns fast track designation for treatment of nAMD
September 14th 2025

SAR402663 earns fast track designation for treatment of nAMD

© 2025 MJH Life Sciences

All rights reserved.